Skip to main content

Table 4 Symptom Score 0–6 months: sensitivity analyses (SA)

From: Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings

Analysis

N

0 months

6 months

0–6 month difference

  

Mean (SD)

Mean (SD)

Mean (95%-CI)

P-value

Main analysis: Patients with evaluable Symptom Score at 0 and 6 months

381

6.21 (1.76)

3.80 (2.34)

2.41 (2.16–2.66)

< 0.001

SA1: Last value carried forward

433

6.15 (1.80)

3.87 (2.35)

2.28 (2.05–2.52)

< 0.001

SA2: Patients with disease duration ≥ 12 months at study enrolment

320

6.29 (1.76)

3.91 (2.28)

2.39 (2.13–2.65)

< 0.001

SA1 + SA2

364

6.24 (1.78)

3.96 (2.30)

2.28 (2.03–2.52)

< 0.001

Patients with main diagnosis of mental, musculoskeletal or respiratory diseases, headache disorders or urinary incontinence

     

Main analysis: Patients with evaluable Symptom Score at 0 and 6 months

297

6.26 (1.72)

3.84 (2.35)

2.42 (2.13–2.71)

< 0.001

SA3: Patients not using diagnosis-related non-anthroposophic therapies (see Table 1) in months 0–6

239

6.32 (1.71)

3.69 (2.29)

2.63 (2.32–2.95)

< 0.001

SA1 + SA2 + SA3

204

6.40 (1.71)

3.87 (2.21)

2.54 (2.22–2.86)

< 0.001